Company Purple Biotech Ltd Nasdaq

Equities

PPBT

US74638P1093

Biotechnology & Medical Research

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Quarterly revenue - Rate of surprise

Sector Bio Therapeutic Drugs

Market Closed - Nasdaq Other stock markets 16:30:00 2024-05-17 EDT			5-day change	1st Jan Change
0.554 ^USD	+10.34%		+5.50%	-28.97%

04-25	Purple Biotech Ltd.'s Randomized Phase 2 CM24 Pancreatic Cancer Study Selected as Late-Breaking Abstract Poster Presentation at ASCO 2024 Annual Meeting	CI
03-14	Purple Biotech Reports Preclinical Proof of Concept for Its Tribody Platform Technology	CI

Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.

Number of employees: 20

Managers	Title	Age	Since
Gil Efron CEO	Chief Executive Officer	57	18-10-10
Lior Fhima DFI	Director of Finance/CFO	-	22-11-01
Ido Morpurgo COO	Chief Operating Officer	51	20-07-31
Hadas Reuveni CTO	Chief Tech/Sci/R&D Officer	56	16-12-31
Bertrand C. Liang CTO	Chief Tech/Sci/R&D Officer	61	20-01-08
Isaac Israel BRD	Director/Board Member	44	12-09-30
Simcha Rock BRD	Director/Board Member	73	13-07-10
Yisrael Gewirtz AUD	Comptroller/Controller/Auditor	47	16-06-30
William Berlin PRN	Corporate Officer/Principal	-	-
Michael Schickler LAW	General Counsel	55	19-12-31

Members of the board	Title	Age	Since
Eric Rowinsky CHM	Chairman	67	19-10-01
Yael Margolin BRD	Director/Board Member	70	12-19
Simcha Rock BRD	Director/Board Member	73	13-07-10
Ido Agmon BRD	Director/Board Member	46	16-06-26
Robert Gagnon BRD	Director/Board Member	49	21-03-02
Suzana Nahum Zilberberg BRD	Director/Board Member	53	21-05-18
Isaac Israel BRD	Director/Board Member	44	12-09-30
Ori Hershkovitz BRD	Director/Board Member	49	21-12-28

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	273,959,287	272,562,367 ( 99.49 %)	0	99.49 %

Name	Equities	%	Valuation
Jason Carrick 4.048 %	10,520,000	4.048 %	591 855 $
KSM Mutual Funds Ltd. 0.1413 %	367,133	0.1413 %	20 655 $
Migdal Mutual Funds Ltd. 0.0873 %	226,876	0.0873 %	12 764 $

Name	Equities	%	Valuation
Armistice Capital LLC 9.617 %	2,499,384	9.617 %	1 M $
Armistice Capital LLC 8.138 %	2,115,000	8.138 %	1 M $
Kingswood Wealth Advisors LLC 0.7160 %	186,100	0.7160 %	96 028 $
Morgan Stanley Capital Services LLC 0.5256 %	136,610	0.5256 %	70 491 $
Citadel Securities GP LLC 0.2232 %	58,023	0.2232 %	29 940 $
XTX Topco Ltd. 0.1120 %	29,099	0.1120 %	15 015 $
Millennium Management LLC 0.0825 %	21,438	0.0825 %	11 062 $
Venture Visionary Partners LLC 0.0598 %	15,553	0.0598 %	8 025 $
Wealth Advisors of Iowa LLC 0.0549 %	14,270	0.0549 %	7 363 $
Geode Capital Management LLC 0.0487 %	12,666	0.0487 %	6 536 $

Purple Biotech Ltd.

Science Park 4 Oppenheimer Street

7670104, Rehovot

+972 3 933 3121

http://ww.purple-biotech.com

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
VERTEX PHARMACEUTICALS INCORPORATED	+9.42%	114B
REGENERON PHARMACEUTICALS, INC.	+11.84%	104B
BIONTECH SE	-14.15%	22.41B
ARGENX SE	-1.05%	22.28B
GENMAB A/S	-5.29%	19.07B
WUXI APPTEC CO., LTD.	-38.29%	18B
BEIGENE, LTD.	-4.16%	17.89B
NEUROCRINE BIOSCIENCES, INC.	+7.99%	14.28B
SAREPTA THERAPEUTICS, INC.	+36.24%	12.55B

Bio Therapeutic Drugs